Analyses of data from the Kaplan-Meier Plotter database indicated that high levels of MAEA expression in GC patients were associated with significantly better overall and disease-free survival (OS and DFS) relative to low MAEA levels (Fig. 1A), and the same was also true in CRC patients (Fig. 1B). This evidence concerns the gene MAEA and colorectal carcinoma.